Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

TARO Taro Pharmaceutical Industries Ltd

42,48

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 10:00:00

Verzögert um 15 Minuten

Annual and Transition Report (foreign Private Issuer) (20-f)

This article is 5Mb in size. Click here to view

Taro Pharmaceutical Indu... (NYSE:TARO)
Historical Stock Chart
Von Mär 2024 bis Apr 2024

Click Here for more Taro Pharmaceutical Indu... Charts.

Taro Pharmaceutical Indu... (NYSE:TARO)
Historical Stock Chart
Von Apr 2023 bis Apr 2024

Click Here for more Taro Pharmaceutical Indu... Charts.

News Taro Pharmaceutical Industries Ltd

Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
Montag 15 April 2024 (2 Wochen vor) • Business Wire

Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
Montag 11 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13E3 - Going private transaction by certain issuers
Donnerstag 15 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Kuehn Law Encourages PGTI, TAST, TARO, and ANSS Investors to Contact Law Firm
Dienstag 30 Januar 2024 (3 Monate vor) • PR Newswire (US)

Krensavage Asset Management Remains Opposed to Sun's Predatory Bid for Taro
Dienstag 30 Januar 2024 (3 Monate vor) • PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Freitag 26 Januar 2024 (3 Monate vor) • Edgar (US Regulatory)

Taro Provides Results for December 31, 2023
Donnerstag 25 Januar 2024 (3 Monate vor) • Business Wire

Taro to Release Third Quarter Results on January 25, 2024
Freitag 19 Januar 2024 (3 Monate vor) • Business Wire

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mittwoch 17 Januar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Mittwoch 17 Januar 2024 (3 Monate vor) • Edgar (US Regulatory)

Taro Announces Merger Agreement with Sun Pharma
Mittwoch 17 Januar 2024 (3 Monate vor) • PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Donnerstag 4 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Weitere Taro Pharmaceutical Industries Ltd News-Artikel

BNP Paribas (QX)

Deutsche Lufthansa

Health Care Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen